[Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003].

Spaeth, Dominique; Casadevall, Nicole; Daouphars, Mikaël; Marchal, Christian; Marec-Berard, Perrine; Fabre, Nicolas; Haugh, Margaret

[Summary version of the Standards, Options and Recommendations for the use of recombinant erythropoietin (epoietin-alpha and beta, darbepoietin-alpha, EPO) in the management of anaemia in oncology - Update 2003]. / Recommandations pour la pratique clinique: standards, Options et Recommandations 2003 pour l'utilisation de l'érythropoïétine recombinante (époetine alfa et bêta, darbepoetine alfa, EPO) dans la prise en charge de l'anémie en cancérologie, mise à jour (rapport abrégé).

Spaeth, Dominique; Casadevall, Nicole; Daouphars, Mikaël; Marchal, Christian; Marec-Berard, Perrine; Fabre, Nicolas; Haugh, Margaret.

Spaeth D; Oncologue médical, Centre Alexis Vautrin, Nancy.

Bull Cancer ; 91(2): 179-88, 2004 Feb.

Article en Fr | MEDLINE | ID: mdl-15047458

Asunto(s)

Anemia/tratamiento farmacológico; Eritropoyetina/uso terapéutico; Neoplasias/complicaciones; Anemia/sangre; Anemia/etiología; Francia; Hemoglobina A/análisis; Humanos; Neoplasias/sangre; Ensayos Clínicos Controlados Aleatorios como Asunto; Proteínas Recombinantes

Search on Google

Imprimir

XML

PubMed Links

Banco de datos: MEDLINE Asunto principal: Eritropoyetina / Anemia / Neoplasias Tipo de estudio: Clinical_trials / Etiology_studies / Guideline / Systematic_reviews Límite: Humans País como asunto: Europa Idioma: Fr Año: 2004 Tipo del documento: Article

Search on Google

Imprimir

XML

PubMed Links